Cleared Traditional

K142180 - TELESENSE

K142180 is an FDA 510(k) clearance for TELESENSE, manufactured by Scottcare Corporation. The device is a Class 2 Cardiovascular device with product code DSI cleared through the Traditional 510(k) pathway after a 126-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2014
Decision
126d
Days
Class 2
Risk

K142180 is an FDA 510(k) clearance for the TELESENSE. Classified as Detector And Alarm, Arrhythmia (product code DSI), Class II - Special Controls.

Submitted by Scottcare Corporation (Cleveland, US). The FDA issued a Cleared decision on December 12, 2014 after a review of 126 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Scottcare Corporation devices

FDA 510(k) Submission Details - K142180

510(k) Number K142180 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 08, 2014
Decision Date December 12, 2014
Days to Decision 126 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
1d slower than avg
Panel avg: 125d · This submission: 126d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DSI Device Classification - Class 2, Special Controls

Product Code DSI Detector And Alarm, Arrhythmia
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DSI Detector And Alarm, Arrhythmia

All 263
Devices cleared under the same product code (DSI) and FDA review panel - the closest regulatory comparables to K142180.
Medtronic Patient Asistant
K150117 · Medtronic, Inc. · May 2015
IntelliVue Patient Monitor
K150310 · Philips Medizin Systeme Boeblingen GmbH · May 2015
MENNTOR X7
K141441 · Mennen Medical , Ltd. · Jan 2015
ACUITY CENTRAL MONITORING STATION OR ACUITY CENTRAL MONITORING SYSTEM, MOBILE ACUITY LT, MOBILE ACUITY, MOBILE LT
K120774 · Welch Allyn, Inc. · Apr 2012
INTELLIVUE MX40 PATIENT MONITOR
K113125 · Philips Medical Systems · Nov 2011
REVEAL XT INSERTABLE CARDIAC MONITOR, MODEL 9529 AND REVEAL DX INSERTABLE CARDIAC MONITOR, MODEL 9528
K103764 · Medtronic, Inc. · May 2011